Zachary Sutton: Translating the 2026 KDIGO Guideline Into Practice
Zachary Sutton, Director of Medical Operations, Transplant Program Coordinator at Carolina Nephrology, PA, Adjunct Assistant Professor at Medical University of South Carolina, shared a post on LinkedIn about a recent article by Susan Hedayati et al, published in Annals of Internal Medicine, adding:
“The 2026 KDIGO anemia guideline updates how we manage anemia in CKD by emphasizing individualized treatment over a one-size-fits-all approach.
Key takeaways include:
- Use ferritin and TSAT to guide iron therapy, with IV iron preferred for patients on hemodialysis
- Address reversible causes of anemia before starting ESA or HIF-PHI therapy
- ESAs remain the preferred first-line therapy over HIF-PHIs
- Individualize when to initiate ESA therapy based on symptoms, comorbidities, and patient preferences
- Maintain hemoglobin below 11.5 g/dL during ESA treatment
For nephrology teams, the message is clear: treat the patient, not simply the hemoglobin number.
The updated guideline gives us a more personalized framework for balancing iron replacement, anemia symptoms, transfusion avoidance, and treatment risk across the CKD spectrum.
A useful update for anyone managing patients with advanced CKD or dialysis.”
Title: Evaluation and Management of Anemia in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2026 Clinical Practice Guideline
Authors: S. Susan Hedayati, Jodie L. Babitt, Jeffrey S. Berns, Biykem Bozkurt, Rebecca S. Cheung, Yarieli Cuevas, Emmanuel E. Effa, Michele F. Eisenga, Steven Fishbane, Yelena Z. Ginzburg, Volker H. Haase, Siah Kim, Jose A. Moura-Neto, Patrick Rossignol, Manisha Sahay, Tetsuhiro Tanaka, Angela Yee-Moon Wang, David C. Wheeler, Karen A. Robinson, Lisa M. Wilson, Renée F. Wilson, Jennifer M. King, Amy Earley, Elie A. Akl, Marcello Tonelli, Evi V. Nagler
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 17, 2026, 14:43Leah Williams: Evaluating Medical Device Haemocompatibility Under ISO 10993-4
-
Sep 17, 2026, 14:32Ria Ahuja: Scaling Evidence-Informed Anemia Interventions Through Training
-
Sep 17, 2026, 14:23Neil Blumberg: ABO Nonidentical Transfusions and Mortality in Massive Transfusion
-
Sep 17, 2026, 14:21Jay Mohan: Thrombectomy and Balloon Angioplasty for Pacemaker-Induced Thrombosis
-
Sep 17, 2026, 14:03Thomas Pincez: Estimating the Effect of Fetal Hemoglobin on Sickle Cell Trait Using Polygenic Scores
-
Sep 17, 2026, 13:52Ashley George: Blood Clots Remain the Leading Cause of Maternal Death in UK
-
Sep 17, 2026, 13:09Mehak Trehan: New Perspectives on Anemia Management in CKD
-
Sep 17, 2026, 10:08WFH 2027 Comprehensive Care Summit Opens Abstract Submissions – World Federation of Hemophilia
-
Sep 17, 2026, 09:56Marianne Yee: MySCDstory Expands Access to Multilingual Sickle Cell Education